nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—Proteasome Degradation—UCHL1—gallbladder cancer	0.0522	0.0744	CbGpPWpGaD
Glucosamine—TNF—EV release from cardiac cells and their functional effects—ERBB4—gallbladder cancer	0.0514	0.0732	CbGpPWpGaD
Glucosamine—IFNG—epithelium—gallbladder cancer	0.0417	0.14	CbGeAlD
Glucosamine—IFNG—pancreas—gallbladder cancer	0.0371	0.124	CbGeAlD
Glucosamine—NFKB2—liver—gallbladder cancer	0.0348	0.117	CbGeAlD
Glucosamine—NFKB2—Inflammasomes—BCL2—gallbladder cancer	0.0329	0.0469	CbGpPWpGaD
Glucosamine—TNF—lymph node—gallbladder cancer	0.0271	0.0908	CbGeAlD
Glucosamine—MMP9—epithelium—gallbladder cancer	0.0268	0.0897	CbGeAlD
Glucosamine—NFKB2—lymph node—gallbladder cancer	0.0267	0.0895	CbGeAlD
Glucosamine—MMP9—pancreas—gallbladder cancer	0.0238	0.0799	CbGeAlD
Glucosamine—IFNG—liver—gallbladder cancer	0.0236	0.0792	CbGeAlD
Glucosamine—IFNG—lymph node—gallbladder cancer	0.0181	0.0607	CbGeAlD
Glucosamine—NFKB2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—BCL2—gallbladder cancer	0.0158	0.0225	CbGpPWpGaD
Glucosamine—MMP9—liver—gallbladder cancer	0.0152	0.0508	CbGeAlD
Glucosamine—TNF—Overview of nanoparticle effects—BCL2—gallbladder cancer	0.0129	0.0184	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—BCL2—gallbladder cancer	0.012	0.0172	CbGpPWpGaD
Glucosamine—MMP9—lymph node—gallbladder cancer	0.0116	0.039	CbGeAlD
Glucosamine—IFNG—ATF-2 transcription factor network—BCL2—gallbladder cancer	0.0112	0.016	CbGpPWpGaD
Glucosamine—TNF—RXR and RAR heterodimerization with other nuclear receptor—BCL2—gallbladder cancer	0.01	0.0143	CbGpPWpGaD
Glucosamine—IFNG—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00922	0.0131	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—NRAS—gallbladder cancer	0.0089	0.0127	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—ERBB3—gallbladder cancer	0.00879	0.0125	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—BCL2—gallbladder cancer	0.00848	0.0121	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—NRAS—gallbladder cancer	0.00841	0.012	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—NRAS—gallbladder cancer	0.00841	0.012	CbGpPWpGaD
Glucosamine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—BCL2—gallbladder cancer	0.00829	0.0118	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—ERBB2—gallbladder cancer	0.00824	0.0117	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—KRAS—gallbladder cancer	0.00766	0.0109	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—EGFR—gallbladder cancer	0.00766	0.0109	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—ERBB4—gallbladder cancer	0.00759	0.0108	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—NRAS—gallbladder cancer	0.00758	0.0108	CbGpPWpGaD
Glucosamine—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—gallbladder cancer	0.00752	0.0107	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—BCL2—gallbladder cancer	0.0074	0.0106	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—KRAS—gallbladder cancer	0.00724	0.0103	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—KRAS—gallbladder cancer	0.00724	0.0103	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—NRAS—gallbladder cancer	0.00718	0.0102	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—gallbladder cancer	0.00716	0.0102	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—BCL2—gallbladder cancer	0.00708	0.0101	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—BCL2—gallbladder cancer	0.00684	0.00974	CbGpPWpGaD
Glucosamine—CYP2C19—liver—gallbladder cancer	0.0068	0.0228	CbGeAlD
Glucosamine—IFNG—Regulation of Telomerase—EGFR—gallbladder cancer	0.00675	0.00961	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—ERBB3—gallbladder cancer	0.00656	0.00936	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—KRAS—gallbladder cancer	0.00653	0.0093	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—HRAS—gallbladder cancer	0.00651	0.00928	CbGpPWpGaD
Glucosamine—IFNG—IL2-mediated signaling events—HRAS—gallbladder cancer	0.00651	0.00928	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—NRAS—gallbladder cancer	0.00631	0.009	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—NRAS—gallbladder cancer	0.00627	0.00893	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—KRAS—gallbladder cancer	0.00618	0.0088	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—HRAS—gallbladder cancer	0.00615	0.00877	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—HRAS—gallbladder cancer	0.00615	0.00877	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—BCL2—gallbladder cancer	0.00614	0.00875	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—gallbladder cancer	0.0058	0.00827	CbGpPWpGaD
Glucosamine—IFNG—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00555	0.00791	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—gallbladder cancer	0.00553	0.00789	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—KRAS—gallbladder cancer	0.00543	0.00774	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—KRAS—gallbladder cancer	0.00539	0.00769	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—EGFR—gallbladder cancer	0.00537	0.00765	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—BCL2—gallbladder cancer	0.00535	0.00763	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.00525	0.00748	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—EGFR—gallbladder cancer	0.00524	0.00746	CbGpPWpGaD
Glucosamine—CYP2E1—liver—gallbladder cancer	0.00499	0.0167	CbGeAlD
Glucosamine—NFKB2—Immune System—KEAP1—gallbladder cancer	0.00491	0.007	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—gallbladder cancer	0.00488	0.00695	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—gallbladder cancer	0.00479	0.00683	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.0047	0.00669	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—HRAS—gallbladder cancer	0.00462	0.00658	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—HRAS—gallbladder cancer	0.00458	0.00653	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—EGFR—gallbladder cancer	0.00434	0.00619	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—HRAS—gallbladder cancer	0.00431	0.00614	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00428	0.0061	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00428	0.0061	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—gallbladder cancer	0.00419	0.00598	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—gallbladder cancer	0.00419	0.00597	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—ERBB2—gallbladder cancer	0.00412	0.00587	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00404	0.00576	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB4—gallbladder cancer	0.00401	0.00571	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—gallbladder cancer	0.004	0.0057	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KEAP1—gallbladder cancer	0.00398	0.00567	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—BCL2—gallbladder cancer	0.00393	0.00559	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—HRAS—gallbladder cancer	0.00383	0.00545	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—gallbladder cancer	0.00381	0.00543	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—gallbladder cancer	0.00364	0.00519	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—gallbladder cancer	0.00352	0.00502	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB3—gallbladder cancer	0.00346	0.00494	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00344	0.0049	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—EGFR—gallbladder cancer	0.00329	0.00469	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—HRAS—gallbladder cancer	0.00317	0.00452	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.00313	0.00446	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—gallbladder cancer	0.00303	0.00432	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—HRAS—gallbladder cancer	0.00302	0.00431	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00295	0.0042	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.00285	0.00407	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—gallbladder cancer	0.00276	0.00394	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—NRAS—gallbladder cancer	0.0027	0.00384	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.0027	0.00384	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—gallbladder cancer	0.00269	0.00384	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00257	0.00367	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00254	0.00361	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—BCL2—gallbladder cancer	0.0024	0.00343	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00239	0.0034	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB4—gallbladder cancer	0.00233	0.00332	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—gallbladder cancer	0.00233	0.00332	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—KRAS—gallbladder cancer	0.00232	0.00331	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.00229	0.00326	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—BCL2—gallbladder cancer	0.00223	0.00319	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—gallbladder cancer	0.00222	0.00316	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—gallbladder cancer	0.00217	0.00309	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.00216	0.00307	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—gallbladder cancer	0.00212	0.00301	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00205	0.00293	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00203	0.0029	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB3—gallbladder cancer	0.00202	0.00287	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—EGFR—gallbladder cancer	0.00201	0.00287	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00198	0.00282	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.00197	0.00281	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB4—gallbladder cancer	0.00189	0.00269	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.00175	0.00249	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—gallbladder cancer	0.00169	0.00241	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.00167	0.00238	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NRAS—gallbladder cancer	0.00165	0.00235	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB3—gallbladder cancer	0.00163	0.00233	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—NRAS—gallbladder cancer	0.00161	0.00229	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.00152	0.00216	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—gallbladder cancer	0.00151	0.00215	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EGFR—gallbladder cancer	0.0015	0.00214	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—EGFR—gallbladder cancer	0.00147	0.00209	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.00143	0.00204	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—KRAS—gallbladder cancer	0.00142	0.00203	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—KRAS—gallbladder cancer	0.00139	0.00197	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.00137	0.00195	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—gallbladder cancer	0.00136	0.00194	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—BCL2—gallbladder cancer	0.0013	0.00186	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00129	0.00184	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—gallbladder cancer	0.00127	0.00182	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—gallbladder cancer	0.00126	0.0018	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—gallbladder cancer	0.00121	0.00172	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—gallbladder cancer	0.00118	0.00168	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00115	0.00164	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NRAS—gallbladder cancer	0.00115	0.00164	CbGpPWpGaD
Glucosamine—IFNG—Immune System—BCL2—gallbladder cancer	0.00105	0.0015	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EGFR—gallbladder cancer	0.00105	0.00149	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—gallbladder cancer	0.00102	0.00146	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—KRAS—gallbladder cancer	0.000988	0.00141	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NRAS—gallbladder cancer	0.000962	0.00137	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB4—gallbladder cancer	0.000926	0.00132	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—gallbladder cancer	0.000924	0.00132	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EGFR—gallbladder cancer	0.000877	0.00125	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—gallbladder cancer	0.00084	0.0012	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KRAS—gallbladder cancer	0.000828	0.00118	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB3—gallbladder cancer	0.000801	0.00114	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NRAS—gallbladder cancer	0.00078	0.00111	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EGFR—gallbladder cancer	0.00071	0.00101	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—gallbladder cancer	0.000704	0.001	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NRAS—gallbladder cancer	0.000703	0.001	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KRAS—gallbladder cancer	0.000671	0.000956	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EGFR—gallbladder cancer	0.000641	0.000913	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—KRAS—gallbladder cancer	0.000605	0.000863	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—gallbladder cancer	0.00057	0.000813	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—gallbladder cancer	0.000514	0.000733	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—gallbladder cancer	0.000502	0.000716	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NRAS—gallbladder cancer	0.000382	0.000544	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EGFR—gallbladder cancer	0.000348	0.000496	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KRAS—gallbladder cancer	0.000329	0.000469	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—gallbladder cancer	0.000292	0.000416	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—gallbladder cancer	0.000279	0.000398	CbGpPWpGaD
